{"title":"How COVID broke my heart: a case report of tamponade after SARS-CoV-2 infection","authors":"Michael Pietrangelo, Jeremy P. Hess, Lauren Ellis","doi":"10.21037/JECCM-21-11","DOIUrl":null,"url":null,"abstract":"SARS-CoV-2 leading to COVID-19 is a global pandemic, the likes of which have been unprecedented in our lifetime, with many presentations, unknown complications, and few effective treatment options. The most common organ affected by COVID-19 is the lungs, but another well-known effect of COVID-19 infection is thromboembolic phenomena. In this case, a patient previously infected with SARSCoV-2 developed chest pain radiating to the back, shortness of breath, and marked hypertension and was diagnosed with an acute ST-segment elevation myocardial infarction (STEMI) complicated by a moderate pericardial effusion which led to a cardiac tamponade. The patient had all three of the components of Beck's Triad: muffled heart sounds, jugular venous distention, and hypotension as well as a narrow pulse pressure and had COVID-19 induced myocarditis resulting in a pericardial effusion and tamponade physiology. This COVID-19 associated pericardial effusion has, to our knowledge, been reported only six times in the literature and this presentation was unique because the patient was in the subacute phase with COVID-19, had a cardiac tamponade, and had a thrombosed stent during the catheterization despite being on long term apixaban. The patient underwent emergency percutaneous coronary intervention (PCI) with two stents and was transferred to the intensive care unit where he was noted to have worsening hypotension despite aggressive vasopressor support. Ultimately, despite an emergent bedside pericardiocentesis, the patient succumbed to complications of COVID-19 infection. To our knowledge, there have only been six reported cases in the literature of COVID-19 associated pericardial effusions, and four had cardiac tamponade. It is imperative that clinicians be wary of, and educated about, the less common effects of COVID-19 infection even after the acute phase has passed, which include a persistent prothrombotic state. © Journal of Emergency and Critical Care Medicine. All rights reserved.","PeriodicalId":73727,"journal":{"name":"Journal of emergency and critical care medicine (Hong Kong, China)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of emergency and critical care medicine (Hong Kong, China)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/JECCM-21-11","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
COVID如何伤了我的心:SARS-CoV-2感染后填塞的病例报告
导致COVID-19的SARS-CoV-2是一种全球性的大流行,这种流行病在我们的一生中是前所未有的,有许多表现,未知的并发症,很少有有效的治疗选择。受COVID-19影响最常见的器官是肺,但COVID-19感染的另一个众所周知的影响是血栓栓塞现象。在本病例中,患者先前感染SARSCoV-2,出现胸痛放射至背部、呼吸急促和明显高血压,并被诊断为急性st段抬高型心肌梗死(STEMI),并发中度心包积液,导致心脏压塞。患者具有贝克三联征的所有三个组成部分:心音低沉、颈静脉扩张、低血压以及脉压狭窄,并患有COVID-19诱导的心肌炎,导致心包积液和心包填塞生理。据我们所知,这种与COVID-19相关的心包积液在文献中仅报道过6次,而且这种表现是独特的,因为患者处于COVID-19亚急性期,有心脏填塞,尽管长期服用阿哌沙班,但在导管插入术期间有血栓支架。该患者接受了紧急经皮冠状动脉介入治疗(PCI),植入了两个支架,并被转移到重症监护病房,尽管给予积极的血管加压药物支持,但仍发现低血压恶化。最终,尽管进行了紧急床边心包穿刺术,但患者还是死于COVID-19感染并发症。据我们所知,文献中仅报道了6例与COVID-19相关的心包积液,其中4例有心脏填塞。临床医生必须警惕并了解COVID-19感染的不太常见的影响,即使在急性期过去之后,其中包括持续的血栓前状态。©《急诊与重症医学杂志》。版权所有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。